Biotechnology

Wuhan General Group Launches Hemp Product Research & Development Division

December 23, 2020 10:25 AM

CAPE TOWN, SA / ACCESSWIRE / December 23, 2020 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce the following corporate update: The Company is pleased to inform its shareholders that it is positioning itself in the rapidly expanding hemp industry by launching the M2BIO Hemp Product Research and Development...

Read more

OMNICANNA Appoints Thermic Paint Partner, Jean-Christophe Gerard, to the Board of Directors and Operations Responsibility of Chief Technology Officer (CTO), Ignites OMNICANNA/Thermic Acquisition with New Consumer Product Lines and Revenue Growth Through USA Expansion Plans

December 23, 2020 9:15 AM

NASHVILLE, TN / ACCESSWIRE / December 23, 2020 / Omnicanna Health Solutions, Inc. (OTC PINK:ENDO), a U.S. Company specializing in hemp formulation-based health and wellness solutions, is pleased to announce it has appointed Mr. Jean-Christophe Gerard to the Company Board of Directors and operations responsibility of Chief Technology Officer (CTO). Mr. Gerard's successful engineering background and firsthand knowledge at Thermic developing...

Read more

Helix BioPharma Corp. Finalizes Polish Subsidiary Divestiture

December 22, 2020 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / December 22, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced that it has closed the transaction with CAIAC Fund Management AG ("CAIAC") for the Company's remaining holdings in its Polish subsidiary, Helix Immuno-Oncology...

Read more

BioSpyder Announces Direct-to-Consumer COVID-19 Screening Service

December 22, 2020 8:00 AM

"TestTheTeam" is a convenient, cost effective test kit for your business or family SAN DIEGO, CA / ACCESSWIRE / December 22, 2020 / BioSpyder Technologies, Inc. is announcing it is selling COVID-19 surveillance screening kits to businesses and consumers via its new ecommerce site testtheteam.com (live on Tuesday, December 22). The service, which utilizes the BioSpyder TempO-SPan technology, aims to relieve the pressure on America's COVID-19...

Read more

Still Time for Federal Government to Act to Protect Patient Access to New Medicines and Vaccines Before January 1, 2021 Implementation of New PMPRB Regulations and Guidelines

December 21, 2020 9:30 AM

OTTAWA, ON / ACCESSWIRE / December 21, 2020 / Innovative Medicines Canada (IMC) issued the following statement today warning of the impact the Patented Medicines Prices Review Board's (PMPRB's) Final Regulations and Guidelines will have on Canadians' access to new medicines and vaccines if they come into effect January 1, 2021: "Innovative Medicines Canada remains extremely concerned with the Patented Medicine Prices Review Board's (PMPRB's)...

Read more

Wuhan General Group Updates on Second Scientific Paper Published on Psychedelics

December 21, 2020 9:15 AM

CAPE TOWN, SA / ACCESSWIRE / December 21, 2020 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce the following corporate update: The research team funded by Wuhan General Group has successfully published a second paper on psychedelic science. This paper is entitled "Effects and safety of Psilocybe...

Read more

Results of General Meeting of Shareholders Held December 17, 2020

December 21, 2020 9:00 AM

SYDNEY, AUSTRALIA / ACCESSWIRE / December 21, 2020 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced the results of the resolution presented at its General Meeting of Shareholders held December 17, 2020 (Australian Eastern Standard Time). Submission of Matters to a Vote of...

Read more

Hancock Jaffe Deemed Compliant With All NASDAQ Continued Listing Requirements

December 21, 2020 8:30 AM

Company Regains Compliance with NASDAQ Minimum Bid Requirement IRVINE, CA / ACCESSWIRE / December 21, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the Company has received formal notification from the NASDAQ Hearings Panel (the "Panel") that the Company has evidenced full compliance with the minimum bid price requirement and all other...

Read more

Tetra Bio-Pharma Confirms it is on Track to Receive Government Funding

December 21, 2020 6:30 AM

Tetra Provides Update on ARDS-003 Tetra Eyes Global Sepsis Market OTTAWA, ON / ACCESSWIRE / December 21, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced that it expects government funding to help accelerate its sepsis and acute respiratory distress syndrome (ARDS) drug development. As the first Endocannabinoid System...

Read more

Havn Life Sciences Files Preliminary Prospectus in Connection with Bought Deal Equity Financing

December 18, 2020 6:55 PM

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 18, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life") is pleased to announce, further to its previously announced offering (the "Offering") on December 15, 2020, that it has filed a preliminary short form prospectus (the "Preliminary Prospectus") with the securities commissions or similar...

Read more

Else Nutrition Clarifies News Release Regarding Deemed Insider Share Disposition

December 18, 2020 5:30 PM

VANCOUVER, BC / ACCESSWIRE / December 18, 2020 / Else Nutrition Holdings (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) ("Else" or the "Company") wishes to clarify the purpose of the December 15 news release issued on behalf of Ms. Hamutal Yitzhak, the CEO of the Company, announcing the filing of an Early Warning Report required under Canadian laws. Ms. Yitzak did not sell or otherwise dispose of any of the shares referenced in that report. Instead, the...

Read more

JOYN Botanicals Signs Joint Venture Agreement with Cannabis Processor Adastra Labs, to Manufacture and Bring Solucann Powder to Cannabis 3.0 Market

December 18, 2020 10:00 AM

TORONTO, ON / ACCESSWIRE / December 18, 2020 / JOYN Botanicals Ltd. ("JOYN") is pleased to announce it has signed a joint venture ("JV") agreement with Adastra Labs Holdings Ltd. (XTRX) (D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, for the exclusive Canadian use of its patent-pending Solucann water soluble cannabis powder for addition into Cannabis 3.0 beverages, edibles, and other...

Read more

Wuhan General Group Expands into UK Market with Medspresso

December 18, 2020 9:30 AM

CAPE TOWN, SA / ACCESSWIRE / December 18, 2020 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce the following corporate update: The Company is set to expand into the European market with its recently launched Medspresso™ line of CBD infused hot beverages. Medspresso™ is a premium functional beverages...

Read more

Adastra Signs Joint Venture Agreement with JOYN Botanicals to Solidify Cannabis 3.0 Edible and Beverage Technology Partnership

December 18, 2020 7:00 AM

LANGLEY, BC / ACCESSWIRE / December 18, 2020 / Adastra Labs Holdings Ltd. (CSE:XTRX)(FRANKFURT:D2EP) ("Adastra") a Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce it has signed a joint venture ("JV") agreement with JOYN Botanicals Ltd. ("JOYN") for the exploitation of JOYN's patent-pending soluble cannabis powder. Joint Venture Terms Under the terms of the JV agreements, Adastra...

Read more

MJ BIOTECH, INC., Forms a Wholly-Owned Subsidiary, New England Biotech, Inc., Entering the HEMP/AGRICULTURE / EXTRACTION sectors - COVID-19 Test kits Update

December 17, 2020 8:30 AM

CHEYENNE, WY / ACCESSWIRE / December 17, 2020 / MJ BIOTECH INC. (OTCQB:MJTV), today announced that it has incorporated a new company - New England Biotech, Inc., in the State of Maine, to enter the robust HEMP/AGRICULTURE / EXTRACTION business. MJTV management felt it would be a dereliction of responsibility to not enter the explosive opportunity presented by the Covid-19 test kit business due to the relationships it has in this sector. Great...

Read more

Molecular Partners Announces New Clinical Data, Immunomodulation Platform Advances, and Virology Portfolio Strategy

December 17, 2020 1:00 AM

First-in-human data from ongoing phase 1 study of MP0310 (AMG 506) demonstrate encouraging biological activity, including successful localized tumor engagement and saturation Data from ongoing phase 1 COVID-19 study show that MP0420 (ensovibep) is well tolerated in first dose cohort Unique immunomodulation platforms advanced to readiness for candidate generation using CD-3 T cell engagers and pMHC binders Virology...

Read more

MobiWellness Is Now America's Largest Mobile Hormone Replacement Therapy Service

December 16, 2020 11:00 AM

MobiWellness now offers hormone therapy for men and women, right in your home or office, in 20 cities and growing WILMINGTON, DE / ACCESSWIRE / December 16, 2020 / MobiWellness, Inc. is an online platform that helps connect patients with doctors that are hormone therapy experts in the patient's state. What is even more valuable, is that thanks to the MobiWellness platform, there is no longer a need to go visit any clinics or labs again,...

Read more

DECN Provides Testing Update for US, Korea and XPRIZE With Plans for Walk-in Donor Study for at-Home GenViro! Saliva Swift :10 Test Kit

December 16, 2020 9:15 AM

As clinical testing in Pennsylvania nears completion for pro and point of care GenViro! kits, Korean partner initiates PCR validation testing to augment testing of their saliva donors and the XPRIZE samples DECN plans 150 patient donor study to complete its at-home testing kit EUA LOS ANGELES, CA / ACCESSWIRE / December 16, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide...

Read more

Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone

December 16, 2020 8:30 AM

Electrocardiograms Indicate Good Cardiac Function for Both Patients IRVINE, CA / ACCESSWIRE / December 16, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergone heart bypass surgeries utilizing HJLI's CoreoGraft have reached the 30-day milestone and are reported to have good cardiac function. The first two CoreoGraft...

Read more

Havn Life Sciences Hits Major Milestone with Research Partner, Complex Biotech Discovery Ventures

December 16, 2020 8:00 AM

Havn Research signs contract with CBDV, located at The University of British Columbia's Vancouver campus, to begin Health Canada approved research to analyze psilocybin under Havn Life's Section 56 exemption. The results of the analysis will allow Havn Life to begin the development of a library of psilocybin compounds. VANCOUVER, BC / ACCESSWIRE / December 16, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn...

Read more